Go Pro

Czech National Bank Acquires 11,792 Shares of UnitedHealth Group Incorporated $UNH

UnitedHealth Group logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Czech National Bank increased its UnitedHealth Group stake by 4.8% in the second quarter, purchasing 11,792 additional shares and bringing its holdings to 258,493 shares valued at approximately $107.4 million.
  • Analysts maintain a generally positive outlook, with UnitedHealth receiving a consensus “Moderate Buy” rating and an average price target of $455.92. Several firms recently raised their targets, while institutional investors collectively own 87.86% of the stock.
  • UnitedHealth reported quarterly EPS of $6.38, exceeding estimates of $4.94, on revenue of $112.03 billion. The company also raised its quarterly dividend to $2.32 per share, equivalent to an annualized yield of about 2.3%.
  • MarketBeat previews the top five stocks to own by September 1st.

Czech National Bank boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 4.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 258,493 shares of the healthcare conglomerate's stock after purchasing an additional 11,792 shares during the period. UnitedHealth Group comprises about 0.6% of Czech National Bank's portfolio, making the stock its 29th largest holding. Czech National Bank's holdings in UnitedHealth Group were worth $107,437,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of UNH. Vaughan David Investments LLC IL lifted its stake in UnitedHealth Group by 2.7% in the fourth quarter. Vaughan David Investments LLC IL now owns 150,773 shares of the healthcare conglomerate's stock valued at $49,772,000 after acquiring an additional 3,934 shares during the last quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A. lifted its stake in UnitedHealth Group by 1,287.2% in the 1st quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A. now owns 60,022 shares of the healthcare conglomerate's stock valued at $16,241,000 after purchasing an additional 55,695 shares during the last quarter. Vanguard Group Inc. grew its holdings in UnitedHealth Group by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 91,600,260 shares of the healthcare conglomerate's stock worth $30,238,162,000 after purchasing an additional 995,210 shares during the period. PBCay One RSC Ltd bought a new stake in UnitedHealth Group in the first quarter valued at approximately $14,343,000. Finally, Sumitomo Mitsui Financial Group Inc. boosted its stake in shares of UnitedHealth Group by 8.7% during the 4th quarter. Sumitomo Mitsui Financial Group Inc. now owns 102,260 shares of the healthcare conglomerate's stock worth $33,757,000 after acquiring an additional 8,226 shares during the period. Institutional investors own 87.86% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on UNH. TD Cowen increased their price target on UnitedHealth Group from $337.00 to $430.00 and gave the company a "hold" rating in a research note on Tuesday, July 14th. DA Davidson set a $512.00 target price on shares of UnitedHealth Group in a research note on Tuesday, July 21st. Jefferies Financial Group upped their price target on shares of UnitedHealth Group from $340.00 to $373.00 and gave the company a "buy" rating in a research note on Monday, April 20th. Truist Financial raised their price objective on shares of UnitedHealth Group from $440.00 to $480.00 and gave the stock a "buy" rating in a research report on Tuesday, July 14th. Finally, Robert W. Baird raised UnitedHealth Group from an "underperform" rating to a "neutral" rating and upped their target price for the company from $287.00 to $453.00 in a research report on Thursday, July 16th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and five have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $455.92.

View Our Latest Report on UnitedHealth Group

UnitedHealth Group Trading Down 2.1%

UNH opened at $403.94 on Friday. The company has a quick ratio of 0.80, a current ratio of 0.78 and a debt-to-equity ratio of 0.66. UnitedHealth Group Incorporated has a twelve month low of $239.50 and a twelve month high of $461.62. The stock has a market capitalization of $366.84 billion, a price-to-earnings ratio of 25.99, a P/E/G ratio of 1.43 and a beta of 0.62. The company has a 50-day simple moving average of $413.55 and a 200 day simple moving average of $350.44.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, beating the consensus estimate of $4.94 by $1.44. The company had revenue of $112.03 billion during the quarter, compared to analysts' expectations of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The business's revenue for the quarter was up .4% compared to the same quarter last year. During the same period in the previous year, the company earned $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Analysts predict that UnitedHealth Group Incorporated will post 19.69 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th were issued a $2.32 dividend. The ex-dividend date of this dividend was Monday, June 15th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.21. UnitedHealth Group's dividend payout ratio (DPR) is 59.72%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Featured Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines